FDA Approves Nirogacestat Tablets for Rare Desmoid Tumors
The approval is the first for a systemic therapy to treat desmoid tumors, offering patients an alternative to surgery.
Stay updated with breaking news from First Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval is the first for a systemic therapy to treat desmoid tumors, offering patients an alternative to surgery.
Pti: Consider these 8 Factors before Scheduling your First Therapy Session
Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date...
The first topical in vivo gene therapy to reach late-stage development heals dystrophic epidermolysis bullosa wounds, researchers report.
~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for September 23, 2022 ~ ~ If Approved by the FDA, PEDMARKTM Stands to Be the First...